These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37713619)

  • 21. Harnessing public domain data to discover and validate therapeutic targets.
    Reisdorf WC; Chhugani N; Sanseau P; Agarwal P
    Expert Opin Drug Discov; 2017 Jul; 12(7):687-693. PubMed ID: 28494630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TiPs: a database of therapeutic targets in pathogens and associated tools.
    Lepore R; Tramontano A; Via A
    Bioinformatics; 2013 Jul; 29(14):1821-2. PubMed ID: 23698860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging Target Families: Intractable Targets.
    Knapp S
    Handb Exp Pharmacol; 2016; 232():43-58. PubMed ID: 26552403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic target database update 2014: a resource for targeted therapeutics.
    Qin C; Zhang C; Zhu F; Xu F; Chen SY; Zhang P; Li YH; Yang SY; Wei YQ; Tao L; Chen YZ
    Nucleic Acids Res; 2014 Jan; 42(Database issue):D1118-23. PubMed ID: 24265219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systems pharmacology strategies for drug discovery and combination with applications to cardiovascular diseases.
    Li P; Chen J; Wang J; Zhou W; Wang X; Li B; Tao W; Wang W; Wang Y; Yang L
    J Ethnopharmacol; 2014; 151(1):93-107. PubMed ID: 23850710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Druggability Assessment of Targets Used in Kinetic Target-Guided Synthesis.
    Unver MY; Gierse RM; Ritchie H; Hirsch AKH
    J Med Chem; 2018 Nov; 61(21):9395-9409. PubMed ID: 29873484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PfalDB: an integrated drug target and chemical database for Plasmodium falciparum.
    Kumar A; Agarwal N; Pant L; Singh JP; Ghosh I; Subbarao N
    Curr Drug Targets; 2014; 15(12):1089-93. PubMed ID: 25198774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What are next generation innovative therapeutic targets? Clues from genetic, structural, physicochemical, and systems profiles of successful targets.
    Zhu F; Han L; Zheng C; Xie B; Tammi MT; Yang S; Wei Y; Chen Y
    J Pharmacol Exp Ther; 2009 Jul; 330(1):304-15. PubMed ID: 19357322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DrugMAP: molecular atlas and pharma-information of all drugs.
    Li F; Yin J; Lu M; Mou M; Li Z; Zeng Z; Tan Y; Wang S; Chu X; Dai H; Hou T; Zeng S; Chen Y; Zhu F
    Nucleic Acids Res; 2023 Jan; 51(D1):D1288-D1299. PubMed ID: 36243961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL.
    Mutowo P; Bento AP; Dedman N; Gaulton A; Hersey A; Lomax J; Overington JP
    J Biomed Semantics; 2016 Sep; 7(1):59. PubMed ID: 27678076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TheMarker: a comprehensive database of therapeutic biomarkers.
    Zhang Y; Zhou Y; Zhou Y; Yu X; Shen X; Hong Y; Zhang Y; Wang S; Mou M; Zhang J; Tao L; Gao J; Qiu Y; Chen Y; Zhu F
    Nucleic Acids Res; 2024 Jan; 52(D1):D1450-D1464. PubMed ID: 37850638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elucidating the druggability of the human proteome with eFindSite.
    Kana O; Brylinski M
    J Comput Aided Mol Des; 2019 May; 33(5):509-519. PubMed ID: 30888556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Freely Accessible Chemical Database Resources of Compounds for In Silico Drug Discovery.
    Yang J; Wang D; Jia C; Wang M; Hao G; Yang G
    Curr Med Chem; 2019; 26(42):7581-7597. PubMed ID: 29737247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What makes a good drug target?
    Gashaw I; Ellinghaus P; Sommer A; Asadullah K
    Drug Discov Today; 2011 Dec; 16(23-24):1037-43. PubMed ID: 21945861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIT 2.0: an enhanced platform for Herbal Ingredients' Targets.
    Yan D; Zheng G; Wang C; Chen Z; Mao T; Gao J; Yan Y; Chen X; Ji X; Yu J; Mo S; Wen H; Han W; Zhou M; Wang Y; Wang J; Tang K; Cao Z
    Nucleic Acids Res; 2022 Jan; 50(D1):D1238-D1243. PubMed ID: 34986599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel therapeutics for complex diseases from genome-wide association data.
    Grover MP; Ballouz S; Mohanasundaram KA; George RA; Sherman CD; Crowley TM; Wouters MA
    BMC Med Genomics; 2014; 7 Suppl 1(Suppl 1):S8. PubMed ID: 25077696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HCDT: an integrated highly confident drug-target resource.
    Chen J; Chen Z; Chen R; Feng D; Li T; Han H; Bi X; Wang Z; Li K; Li Y; Li X; Wang L; Li J
    Database (Oxford); 2022 Nov; 2022():. PubMed ID: 36420558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Network-Based Target Prioritization and Drug Candidate Identification for Multiple Sclerosis: From Analyzing "Omics Data" to Druggability Simulations.
    Yang J; Li H; Wang F; Xiao F; Yan W; Hu G
    ACS Chem Neurosci; 2021 Mar; 12(5):917-929. PubMed ID: 33565875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding site druggability assessment in fragment-based drug design.
    Zhou Y; Huang N
    Methods Mol Biol; 2015; 1289():13-21. PubMed ID: 25709029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.